CEO Reid Waldman Files to Sell $15M in Veradermics Shares
MANE has more than doubled off its 52-week low of $32.
Summary
CEO Reid Waldman plans to sell $15 million in Veradermics stock, adding to recent insider selling pressure.
Key Events · Ownership and Investor Activity · MANE
-
CEO Files to Sell $15M
Reid Alexander Waldman filed Form 144 to sell 135,000 shares valued at approximately $15.0 million.
-
Sale Includes Founder Shares
131,548 shares are founder shares acquired in March 2020; 3,452 shares are from stock options exercised on August 17, 2026.
-
Adds to Insider Selling
This follows $10.7 million in sales by Director John W. Childs on August 12 and Form 144s from SR One Capital and AMZL, LP on August 12.
-
No Prior CEO Sales
This is the first Form 144 filed by the CEO in the last 90 days, marking a new insider selling signal.
Analysis · MANE · Life Sciences
A significant liquidity event is unfolding at Veradermics, as CEO Reid Alexander Waldman has filed a Form 144 to sell 135,000 shares worth approximately $15.0 million. This marks the first insider sale by the CEO, following recent sales by other insiders and investment funds. The sale includes founder shares and newly exercised options, indicating a notable move by the company's top executive.
At the time of this filing, MANE was trading at $108.22 on NYSE in the Life Sciences sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $32.00 to $131.24. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.